W&W Group Deepens Partnership with Regnology to Future-Proof Regulatory Reporting Infrastructure
8.10.2025 09:59:00 CEST | Business Wire | Press Release
Regnology, a global leading software provider of regulatory reporting and supervisory technology solutions, is proud to announce that its client, W&W Group, a prominent German financial services provider, is migrating its on-premise deployment of Regnology’s regulatory reporting solution to the Regnology Reporting Hub (RRH)—a cloud-native banking platform hosted on Rcloud, Regnology’s secure and scalable hyperscale-grade cloud infrastructure. This pivotal transition elevates W&W Group’s agility and resilience.
Headquartered in Kornwestheim, W&W Group provides home financing, insurance, and wealth management services, with total assets of €72.3 billion as of 31 December 2024. Since 2011, the institution has relied on Regnology to manage regulatory and capital market transaction reporting across its banking, insurance, and asset management entities. With the transition to Rcloud-hosted RRH, W&W Group gains access to elastic scalability, robust security, and efficient processing of large regulatory datasets. Rcloud also provides managed services such as batch processing, platform oversight, and continuous updates aligned with regulatory changes.
This strategic migration marks a key milestone in W&W Group’s digital transformation journey, delivering future-proof infrastructure to support long-term growth. W&W Group leverages RRH’s comprehensive coverage across banking regulations—including own funds, liquidity, statistical, Pillar 3 disclosure, deposit insurance, SRB, FinRep, AnaCredit, and transaction-level regimes such as EMIR, MiFIR, SFTR, and MMSR—ensuring compliance across jurisdictions.
Maciej Piechocki, Chief Revenue Officer of Regnology, commented: "We’re proud to support W&W Group’s transformation with best-in-class technologies and modern architecture. Our RRH platform on Rcloud empowers institutions to meet regulatory demands with speed, security, and confidence. This future-ready solution delivers efficiency and scalability needed to navigate evolving industry requirements. We value our partnership with W&W Group and remain committed to supporting their strategic goals and the broader German financial community."
Bernd Groß, Head of Application Development Regulatory Reporting of W&W Group, said: "Partnering with Regnology is crucial for the digital transformation of regulatory reporting. As regulatory complexity and associated technology demands grow, we’re building a resilient, agile, and reliable reporting infrastructure. Regnology’s broad regulatory coverage, deep expertise, and long-standing collaboration make them a trusted partner."
In 2023, Regnology announced its strategic shift to hyperscale-cloud delivery of its industry-leading banking regulatory and tax reporting solutions introducing Rcloud powered by Google Cloud. Today, over 50% of Regnology’s clients have successfully transitioned to the cloud infrastructure and its related managed services across the world, supported by a network of 12+ data centres located in EMEA, APAC, and the Americas. This momentum reflects the industry’s drive toward superior operational efficiency, enhanced resilience, and readiness for AI-driven innovation. Client adoption is projected to reach 80% by Q2 2026.
AboutW&W Group
The W&W Group came into existence in 1999 as a result of the merger of the two long-standing companies Wüstenrot and Württembergische. Today, it develops and provides the four components of modern financial planning: financial security, residential property ownership, risk protection and savings and investment. It combines the Housing and Insurance divisions with the digital initiatives and brands of the group such as Adam Riese, which enables it to offer every customer the financial planning solution that suits them best. In doing so, the W&W Group focuses on omni-channel sales, ranging from its own mobile sales force to cooperation partners and sales agents, broker activities and digital initiatives. Today, approximately 13,000 people work as in-house staff or in the mobile sales force for the listed group headquartered in Kornwestheim, Germany.
About Regnology
Regnology is a leading technology firm on a mission to enhance efficiency, transparency, and stability in the financial markets. Regnology has a focus on regulatory reporting with thousands of financial institutions and corporates of all sizes, and close to 100 regulators and tax authorities as clients. Regnology connects regulators and regulated financial institutions across the world through purpose-built solutions and common standards, bringing greater data quality and cost savings to all. With over 1,200 employees in 25 countries and a fast, flexible, and future-proof platform, clients can quickly implement and derive value from Regnology’s solutions and rely on us to easily keep pace with ongoing regulatory changes.
Regnology was formed in 2021 when BearingPoint RegTech, a former business unit of BearingPoint Group, joined forces with Vizor Software, a global leader in regulatory and supervisory technology.
For more information about Regnology, connect with us on LinkedIn and X.
Visit our website: www.regnology.net.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251008487821/en/
Contacts
Press Contact
Mireille Adebiyi – Chief Marketing Officer, Regnology
mireille.adebiyi@regnology.net
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom